rs781830206

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2

The NM_001111125.3(IQSEC2):​c.2053G>A​(p.Glu685Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000182 in 1,210,458 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E685V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000044 ( 0 hom., 1 hem., cov: 23)
Exomes 𝑓: 0.000015 ( 0 hom. 4 hem. )

Consequence

IQSEC2
NM_001111125.3 missense

Scores

1
5
9

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: 2.58

Publications

0 publications found
Variant links:
Genes affected
IQSEC2 (HGNC:29059): (IQ motif and Sec7 domain ArfGEF 2) This gene encodes a guanine nucleotide exchange factor for the ARF family of small GTP-binding proteins. The encoded protein is a component of the postsynaptic density at excitatory synapses, and may play a critical role in cytoskeletal and synaptic organization through the activation of selected ARF substrates including ARF1 and ARF6. Mutations in this gene have been implicated in nonsyndromic X-linked cognitive disability. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Aug 2011]
IQSEC2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: Ambry Genetics
  • intellectual disability, X-linked 1
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • severe intellectual disability-progressive postnatal microcephaly- midline stereotypic hand movements syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.07511562).
BP6
Variant X-53250523-C-T is Benign according to our data. Variant chrX-53250523-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 471266.
BS2
High Hemizygotes in GnomAdExome4 at 4 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IQSEC2NM_001111125.3 linkc.2053G>A p.Glu685Lys missense_variant Exon 5 of 15 ENST00000642864.1 NP_001104595.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IQSEC2ENST00000642864.1 linkc.2053G>A p.Glu685Lys missense_variant Exon 5 of 15 NM_001111125.3 ENSP00000495726.1

Frequencies

GnomAD3 genomes
AF:
0.0000445
AC:
5
AN:
112378
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0000323
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000561
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000376
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000328
AC:
6
AN:
182656
AF XY:
0.0000298
show subpopulations
Gnomad AFR exome
AF:
0.0000761
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000289
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000123
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000155
AC:
17
AN:
1098026
Hom.:
0
Cov.:
33
AF XY:
0.0000110
AC XY:
4
AN XY:
363398
show subpopulations
African (AFR)
AF:
0.0000379
AC:
1
AN:
26402
American (AMR)
AF:
0.00
AC:
0
AN:
35206
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19386
East Asian (EAS)
AF:
0.000166
AC:
5
AN:
30206
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54147
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40327
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4137
European-Non Finnish (NFE)
AF:
0.0000131
AC:
11
AN:
842127
Other (OTH)
AF:
0.00
AC:
0
AN:
46088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000445
AC:
5
AN:
112432
Hom.:
0
Cov.:
23
AF XY:
0.0000289
AC XY:
1
AN XY:
34586
show subpopulations
African (AFR)
AF:
0.0000322
AC:
1
AN:
31010
American (AMR)
AF:
0.00
AC:
0
AN:
10731
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2651
East Asian (EAS)
AF:
0.000563
AC:
2
AN:
3553
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2684
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6200
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
217
European-Non Finnish (NFE)
AF:
0.0000376
AC:
2
AN:
53165
Other (OTH)
AF:
0.00
AC:
0
AN:
1533
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000189
ExAC
AF:
0.0000412
AC:
5

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Intellectual disability, X-linked 1 Uncertain:2Benign:1
Oct 31, 2018
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 01, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 11, 2018
Institute for Genomic Medicine (IGM) Clinical Laboratory, Nationwide Children's Hospital
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

BP5; This variant was found in a case with an alternate molecular basis of disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.41
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.63
CADD
Benign
22
DANN
Uncertain
1.0
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.94
D;.;D;D
M_CAP
Benign
0.051
D
MetaRNN
Benign
0.075
T;T;T;T
MetaSVM
Benign
-0.99
T
PhyloP100
2.6
PrimateAI
Pathogenic
0.88
D
PROVEAN
Benign
-1.6
.;N;.;N
REVEL
Benign
0.024
Sift
Uncertain
0.028
.;D;.;T
Sift4G
Benign
0.14
.;T;.;T
Polyphen
0.038
.;.;.;B
Vest4
0.37, 0.31
MutPred
0.25
Gain of methylation at E685 (P = 0.0064);Gain of methylation at E685 (P = 0.0064);Gain of methylation at E685 (P = 0.0064);.;
MVP
0.37
MPC
1.2
ClinPred
0.089
T
GERP RS
4.7
PromoterAI
-0.017
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.34
gMVP
0.48
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs781830206; hg19: chrX-53279705; API